PFIZER INC Quarterly Interest Expense in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Pfizer Inc quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q2 2024.
  • Pfizer Inc Interest Expense for the quarter ending June 30, 2024 was $778M, a 53.2% increase year-over-year.
  • Pfizer Inc Interest Expense for the twelve months ending June 30, 2024 was $2.95B, a 104% increase year-over-year.
  • Pfizer Inc annual Interest Expense for 2023 was $2.21B, a 78.4% increase from 2022.
  • Pfizer Inc annual Interest Expense for 2022 was $1.24B, a 4.11% decline from 2021.
  • Pfizer Inc annual Interest Expense for 2021 was $1.29B, a 10.9% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.95B $778M +$270M +53.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $2.68B $790M +$472M +148% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $2.21B $688M +$376M +121% Oct 2, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $1.83B $695M +$384M +123% Jul 3, 2023 Oct 1, 2023 10-Q 2023-11-08
Q2 2023 $1.45B $508M +$215M +73.4% Apr 3, 2023 Jul 2, 2023 10-Q 2024-08-05
Q1 2023 $1.23B $318M -$4M -1.24% Jan 1, 2023 Apr 2, 2023 10-Q 2024-05-08
Q4 2022 $1.24B $312M -$2M -0.64% Oct 3, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $1.24B $311M -$14M -4.31% Jul 4, 2022 Oct 2, 2022 10-Q 2023-11-08
Q2 2022 $1.25B $293M -$23M -7.28% Apr 4, 2022 Jul 3, 2022 10-Q 2023-08-09
Q1 2022 $1.28B $322M -$14M -4.17% Jan 1, 2022 Apr 3, 2022 10-Q 2023-05-10
Q4 2021 $1.29B $314M -$33M -9.51% Oct 4, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $1.32B $325M -$20M -5.8% Jul 5, 2021 Oct 3, 2021 10-Q 2022-11-09
Q2 2021 $1.34B $316M -$51M -13.9% Apr 5, 2021 Jul 4, 2021 10-Q 2022-08-10
Q1 2021 $1.4B $336M -$54M -13.8% Jan 1, 2021 Apr 4, 2021 10-Q 2022-05-11
Q4 2020 $1.45B $347M -$67M -16.2% Sep 28, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $1.52B $345M -$64M -15.6% Jun 29, 2020 Sep 27, 2020 10-Q 2021-11-12
Q2 2020 $1.58B $367M -$22M -5.66% Mar 30, 2020 Jun 28, 2020 10-Q 2021-08-12
Q1 2020 $1.6B $390M +$29M +8.03% Jan 1, 2020 Mar 29, 2020 10-Q 2021-05-13
Q4 2019 $1.57B $414M +$44M +11.9% Sep 30, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $1.53B $409M +$99M +31.9% Jul 1, 2019 Sep 29, 2019 10-Q 2020-11-05
Q2 2019 $1.43B $389M +$63M +19.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.37B $361M +$51M +16.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.32B $370M +$41M +12.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $1.28B $310M -$10M -3.13% Jul 2, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.29B $326M +$14M +4.49% Apr 2, 2018 Jul 1, 2018 10-Q 2019-08-08
Q1 2018 $1.27B $310M +$1M +0.32% Jan 1, 2018 Apr 1, 2018 10-Q 2019-05-09
Q4 2017 $1.27B $329M +$32M +10.8% Oct 2, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $1.24B $320M +$29M +9.97% Jul 3, 2017 Oct 1, 2017 10-Q 2018-11-08
Q2 2017 $1.21B $312M +$20M +6.85% Apr 3, 2017 Jul 2, 2017 10-Q 2018-08-09
Q1 2017 $1.19B $309M +$3M +0.98% Jan 1, 2017 Apr 2, 2017 10-Q 2018-05-10
Q4 2016 $1.19B $297M -$37M -11.1% Oct 3, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $1.22B $291M +$13M +4.68% Jul 4, 2016 Oct 2, 2016 10-Q 2017-11-09
Q2 2016 $1.21B $292M +$14M +5.04% Apr 4, 2016 Jul 3, 2016 10-Q 2017-08-10
Q1 2016 $1.2B $306M -$3M -0.97% Jan 1, 2016 Apr 3, 2016 10-Q 2017-05-11
Q4 2015 $1.2B $334M -$19M -5.38% Sep 28, 2015 Dec 31, 2015 10-K 2018-02-22
Q3 2015 $1.22B $278M -$65M -19% Jun 29, 2015 Sep 27, 2015 10-Q 2016-11-10
Q2 2015 $1.28B $278M -$65M -19% Mar 30, 2015 Jun 28, 2015 10-Q 2016-08-11
Q1 2015 $1.35B $309M -$12M -3.74% Jan 1, 2015 Mar 29, 2015 10-Q 2016-05-12
Q4 2014 $1.36B $353M +$6M +1.73% Sep 29, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 $1.35B $343M +$3M +0.88% Jun 30, 2014 Sep 28, 2014 10-Q 2015-11-05
Q2 2014 $1.35B $343M -$13M -3.65% Mar 31, 2014 Jun 29, 2014 10-Q 2015-08-06
Q1 2014 $1.36B $321M -$50M -13.5% Jan 1, 2014 Mar 30, 2014 10-Q 2015-05-07
Q4 2013 $1.41B $347M -$26M -6.97% Sep 30, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $1.44B $340M -$41M -10.8% Jul 1, 2013 Sep 29, 2013 10-Q 2014-11-06
Q2 2013 $1.48B $356M -$22M -5.82% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $1.5B $371M -$19M -4.87% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $1.52B $373M -$23M -5.81% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $1.55B $381M -$42M -9.93% Jul 2, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $1.59B $378M -$26M -6.44% Apr 2, 2012 Jul 1, 2012 10-Q 2013-08-09
Q1 2012 $1.61B $390M -$68M -14.8% Jan 1, 2012 Apr 1, 2012 10-Q 2013-05-10
Q4 2011 $1.68B $396M -$63M -13.7% Oct 3, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 $1.74B $423M -$4M -0.94% Jul 4, 2011 Oct 2, 2011 10-Q 2012-11-09
Q2 2011 $1.75B $404M +$15M +3.86% Apr 4, 2011 Jul 3, 2011 10-Q 2011-08-11
Q1 2011 $1.73B $458M -$64M -12.3% Jan 1, 2011 Apr 3, 2011 10-Q 2012-05-10
Q4 2010 $1.8B $459M Oct 4, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 $427M Jul 5, 2010 Oct 3, 2010 10-Q 2011-11-10
Q2 2010 $389M Apr 5, 2010 Jul 4, 2010 10-Q 2011-08-11
Q1 2010 $522M Jan 1, 2010 Apr 4, 2010 10-Q 2011-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.